LifeMD (LFMD) Current Deferred Revenue (2018 - 2026)

LifeMD has reported Current Deferred Revenue for 9 years, with the latest figure at $12.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue fell 17.95% year-over-year to $12.0 million; the trailing twelve-month figure through Mar 2026 stood at $12.0 million (down 17.95% YoY), and the FY2025 full-year result was $10.8 million, down 36.84% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $12.0 million, up from $10.8 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $20.6 million in Q3 2024, with the low at $1.8 million in Q1 2022.
• Historically, Current Deferred Revenue has averaged $10.3 million across 5 years, with a median of $10.8 million in 2025.
• Annual changes were most pronounced in 2022 — Current Deferred Revenue jumped 269.86% — and 2025, when it slumped 36.84%.
• LifeMD's Current Deferred Revenue stood at $5.5 million in 2022, then jumped by 31.08% to $7.3 million in 2023, then jumped by 135.16% to $17.1 million in 2024, then sank by 36.84% to $10.8 million in 2025, then rose by 11.11% to $12.0 million in 2026.
• The last three Current Deferred Revenue figures came in at $12.0 million (Q1 2026), $10.8 million (Q4 2025), and $14.4 million (Q3 2025), per Business Quant data.